Open Access Highly Accessed Email this article to a friend

Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration

Lisa M McShane*, Margaret M Cavenagh, Tracy G Lively, David A Eberhard, William L Bigbee, P Mickey Williams, Jill P Mesirov, Mei-Yin C Polley, Kelly Y Kim, James V Tricoli, Jeremy MG Taylor, Deborah J Shuman, Richard M Simon, James H Doroshow and Barbara A Conley

BMC Medicine 2013, 11:220  doi:10.1186/1741-7015-11-220

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive BMC Medicine's emails?